|Day Low/High||2.36 / 2.37|
|52 Wk Low/High||0.82 / 3.10|
In recent trading, shares of Sequenom Inc have crossed above the average analyst 12-month target price of $1.18, changing hands for $2.35/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
Rigrodsky & Long, P.A.
Acquisition Creates Market Leader in NIPT, Women's Health and Reproductive Genetics
Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH), the world's leading healthcare diagnostics company, and Sequenom, Inc.
30% of MaterniT® GENOME positive findings could be detected only with genome-wide testing
Stocks with insider trader activity include KSU, TLMR and SQNM
Shares of the urology company surge in postmarket trading Thursday.
Stocks with insider trader activity include SQNM, OFIX and CIEN
Medical Diagnostics Industry Veteran Will Help Drive Growth of Sequenom Laboratories Tests in New and Existing Channels
Agreement covers Noninvasive Prenatal Tests in California
Test can detect up to 25% more chromosomal information genome-wide than other leading NIPTs